KORU Medical Systems, Inc. (KRMD)
NASDAQ: KRMD · Real-Time Price · USD
4.390
+0.130 (3.05%)
Jan 31, 2025, 4:00 PM EST - Market closed
KORU Medical Systems Revenue
KORU Medical Systems had revenue of $8.18M in the quarter ending September 30, 2024, with 16.80% growth. This brings the company's revenue in the last twelve months to $31.99M, up 11.57% year-over-year. In the year 2023, KORU Medical Systems had annual revenue of $28.52M with 2.23% growth.
Revenue (ttm)
$31.99M
Revenue Growth
+11.57%
P/S Ratio
6.28
Revenue / Employee
$390,168
Employees
82
Market Cap
201.23M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 28.52M | 621.63K | 2.23% |
Dec 31, 2022 | 27.90M | 4.41M | 18.76% |
Dec 31, 2021 | 23.49M | -686.27K | -2.84% |
Dec 31, 2020 | 24.18M | 1.01M | 4.38% |
Dec 31, 2019 | 23.16M | 5.81M | 33.47% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Feb 28, 2017 | Pro | Pro | Pro |
Feb 29, 2016 | Pro | Pro | Pro |
Feb 28, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.95B |
KRMD News
- 2 days ago - KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology - Business Wire
- 19 days ago - KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter - Business Wire
- 2 months ago - KORU Medical Systems to Participate in Piper Sandler's 36th Annual Healthcare Conference - Business Wire
- 2 months ago - KORU Medical Systems, Inc. (KRMD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance - Business Wire
- 3 months ago - KORU Medical Systems to Participate in Upcoming Investor Conferences - Business Wire
- 3 months ago - Impressive Turnaround At KORU Medical - Seeking Alpha
- 3 months ago - KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery (PODD) Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge® Infusion System over Manual Syringe Administration for Subcutaneous Oncology Infusion - Business Wire